Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ring-Shaped Pump Supports Weakened Hearts

By HospiMedica International staff writers
Posted on 12 Jul 2016
An innovative cardiac support system uses peristaltic motion to help the heart pump and transport blood.

Developed by researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), the miniature pump is made of three tiny rings placed around the aorta at the exact spot where it exits the left ventricle. More...
The rings are made of a dielectric electro active polymer (DEAP) with special electrical properties. Each ring has two electrodes that are drawn together by an electrostatic force whenever the electric pulse, provided by magnetic induction, is activated.

Each of the three rings contracts in sequence, in a movement reminiscent of an earthworm. The series of contractions, called peristalsis, creates a wave that moves the blood inside the artery. The double action, both vertical and horizontal, occurs simultaneously and immediately, creating a back-and-forth movement that can be controlled in real time. And since the pump ring does not come into direct contact with the blood, it avoids problems of hemolysis and the subsequent need for regular blood transfusions to replenish the damaged red blood cells (RBCs).

“This method does not require us to enter the heart; this means it is significantly less invasive than other cardiac support systems, which work by implanting valves or screw pumps inside the ventricle,” said Yves Perriard, director of the EPFL Integrated Actuators Laboratory (LAI). “The absence of valves and other components used in current methods to provide cardiac support doesn’t just lessen the possibility of hemolysis. It also makes the insertion and removal of the device significantly easier for surgeons.

The DEAP peristaltic pump is currently in prototype stage. The researchers plan to improve the device’s performance before testing it on a liquid with similar fluidic properties to those of the blood, such as glycerol. The researchers are also in contact with the University Hospital of Bern (Switzerland), where clinical trials could be conducted.

Related Links:
Ecole Polytechnique Fédérale de Lausanne



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Blood Gas Analyzer
i-Check200
New
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.